KOR
ENG
주메뉴
Introduction
Management Philosophy
Introduction to our CI
Histroy
Products
Hutox Inj. 100units
Hutox Inj. 200units
R&D
Notice
메인컨텐츠
PR VIDEO
NOTICE
Huons Group Successfully Hosts Launch Symposium for Botulinum Toxin `Hutox` in China
Huons BioPharma Selected for Funding by the Korea Drug Development Fund to Advance Peptide Eye Drops for Dry Age-related Macular Degeneration.
Huons BioPharma Secures Approval in Kuwait for Botulinum Toxin
Huons BioPharma Appoints Jeonghee Lee as New CEO
Huons BioPharma Dispatches First Shipment of Botulinum Toxin to China
Huons BioPharma Secures NMPA Approval for Type A Botu-linum Toxin in China